Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
about
Endometriosis and ovarian cancer: links, risks, and challenges facedInhibitory receptor immunoglobulin-like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL-10.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer.Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer.Ovarian cancer in endometriosis: clinical and molecular aspects.MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcomeWhole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.MicroRNA-613 inhibited ovarian cancer cell proliferation and invasion by regulating KRAS.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review.Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma.
P2860
Q27003273-91B5A0CA-AAB8-4F96-9E86-2911ECE3533EQ33712699-2313F379-F437-4856-8ECD-57A3E163E49EQ34528553-572F47D7-AD1B-42A6-85A9-CF97ED5BDF80Q36769318-12C05486-45AD-4338-8C16-45B4B53BE1D6Q37610455-5565CCED-C8F1-497C-ACE1-96BDD42AC55DQ37645709-FD17E3D1-D87F-4B31-954A-7A58126C41A2Q37699375-CFF5A6AD-F2EA-4D41-98BB-3F588D9B6AB3Q37724074-A6D7407A-D70F-41F1-9165-1AE1237B00F8Q38669765-6D661202-BEAA-49AE-8513-007144004AE4Q38814833-B3223C86-95EC-4525-BD8C-34F9C9DF8092Q39044222-AE054DE2-E14F-43BA-B784-F45BAB31F973Q39364797-ED418C7A-E702-4BFF-A5CF-AA38F64F30F0Q46879650-E85B2968-1A8A-4447-818F-B34E3AB02EB8
P2860
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinicopathological correlates ...... of epithelial ovarian cancer.
@en
Clinicopathological correlates ...... of epithelial ovarian cancer.
@nl
type
label
Clinicopathological correlates ...... of epithelial ovarian cancer.
@en
Clinicopathological correlates ...... of epithelial ovarian cancer.
@nl
prefLabel
Clinicopathological correlates ...... of epithelial ovarian cancer.
@en
Clinicopathological correlates ...... of epithelial ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Clinicopathological correlates ...... of epithelial ovarian cancer.
@en
P2093
Björn Nodin
Magnus Sundström
Nooreldin Zendehrokh
P2860
P2888
P356
10.1186/1746-1596-8-106
P577
2013-06-25T00:00:00Z
P5875
P6179
1024925822